P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC - Nassar-Reis, Joao Pedro; Umeta, Pedro Fukui; Stefano, José Tadeu; Longatto Filho, Adhemar; Carrilho, Flair José; Alves, Venancio Avancini Ferreira; Cogliati, Bruno; Oliveira, Claudia Pinto Marques Souza de (Journal of molecular histology, 2023)